Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Hyperion Therapeutics, Inc
4237
Hyperion Therapeutics, Inc
Health Care
Technology
Biotechnology
Hyperion Therapeutics is a biopharmaceutical company focused on creating treatments for urea cycle disorders and other rare diseases.
Suggest edits
Founded
2006
Raised
$115M
Follow us
Also headquartered in South San Francisco
Genentech
insitro
MyoKardia
Freenome
SuccessFactors
Plenty
Sutro Biopharma
Theravance
Dispatch
Counsyl
Companies in the same industry
Clensta International BV
Nemysis
Attentive Therapeutics
ReMed
Cavidi
Ackerman Boitech
InSitu Biologics
Iota Biosciences
Cambridge Cancer Genomics
Nuritas
Alexa global traffic share
Overview
Funding
3
Add info
Acquired by
30 Mar 2015
Horizon Pharma plc
$1,100,000,000
Latest funding
Show all
$60,000,000
Venture capital (Series C) - 2009
Highland Capital Partners
NEA
Sofinnova Ventures
+1
$15,000,000
Debt financing - 2007
Comerica Bank
Life Sciences Partners
Location
South San Francisco
,
United States
Headquarters
Explore South San Francisco
No recent coverage
Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Hyperion Therapeutics, Inc makes some noise.
